Can Wegovy cause changes to your periods?

You started Wegovy and your cycle shifted, here is why that can happen

Picture this: three months into treatment, your periods arrive earlier than usual, or you notice they feel heavier than they did before. It can be unsettling, especially when you were not warned to expect it. The reassuring starting point is that semaglutide itself has no known direct effect on the hormones that drive your cycle, oestrogen, progesterone, LH and FSH are not targets of GLP-1 receptor agonists. So what is going on?

Fat tissue is metabolically active. It produces and stores oestrogen, and when body fat falls (sometimes quickly in the first months on Wegovy) circulating oestrogen levels can change. That shift can be enough to disrupt a cycle that was previously predictable. The semaglutide guide on our site explains how the medicine works at a receptor level, which helps frame why systemic effects like this happen as a downstream consequence of weight loss rather than a direct drug action.

There is also an insulin-sensitivity angle. Raised insulin levels suppress normal ovulation signalling in some women; as weight falls and insulin sensitivity improves, that suppression can ease. For some this means a positive change: cycles that were absent or sparse may become more regular. For others it means a temporary adjustment period while the body recalibrates. Both patterns are plausible and both are worth discussing with a clinician if they cause concern. The page on irregular periods and Wegovy goes into more detail on the adjustment phase.

PCOS, weight loss, and the return of periods

Polycystic ovary syndrome is probably the context in which Wegovy's indirect effect on menstruation is most clinically significant. PCOS is closely linked to insulin resistance and is a common driver of irregular or absent periods. Weight loss in women with PCOS (whether through diet alone or medicines) can restore more regular ovulation, and semaglutide is no different in that respect.

This is broadly positive news, but it carries an important practical implication: if your periods return or become more regular while you are taking Wegovy, your fertility may also increase. NHS England's guidance on weight-management injections explicitly notes this point and advises that women who do not wish to become pregnant should use reliable contraception throughout treatment. Wegovy is not recommended during pregnancy or for women trying to conceive, so this matters.

Women using oral contraceptive pills alongside semaglutide should be aware that nausea and vomiting (common in the early weeks of treatment) can reduce how reliably the pill is absorbed. If you vomit within a few hours of taking your pill, the standard missed-pill guidance applies. Your prescriber can help you think through the safest contraceptive approach for your situation. You can also read more about whether semaglutide stops periods if that is the change you have noticed rather than the return of them.

When to speak to someone and what to look out for

Most cycle changes in the first few months of Wegovy are related to the hormonal adjustments that come with weight loss, and they often settle. But there are patterns worth escalating promptly rather than waiting out.

Very heavy bleeding (soaking more than one pad or tampon per hour for several hours) warrants same-day medical attention regardless of whether you are on Wegovy. Bleeding between periods that is new, persistent, or accompanied by pain should be assessed by your GP to rule out gynaecological causes that have nothing to do with your weight-loss treatment. A missed period in a woman who is sexually active should prompt a pregnancy test, given the fertility point above. The separate page on whether Wegovy can stop periods looks at amenorrhoea specifically.

The NHS England resource on weight-management injections is worth bookmarking: it covers contraception, fertility and what to discuss with your clinical team before and during treatment. For a broader overview of how side effects are monitored, the MHRA's Yellow Card scheme allows patients to report any suspected side effect, including unexpected menstrual changes, which contributes to the post-market safety picture for newer medicines like Wegovy.

If you are weighing up Wegovy against other options, the weight-loss treatments overview gives a side-by-side look at what is currently available in the UK. And if cost is part of your thinking, the Wegovy pricing page explains what private treatment typically involves. When you are ready to talk through your specific situation, including how your cycle history might affect the clinical picture, our prescribers are available seven days a week. Speak to our prescribers through a free consultation, every assessment is handled personally, by a real clinician, on the day you submit it.